with his little heart' that he did have a home, a mother and a sister.
Babies that die in the unit without ever having left the hospital are in a sense never born into the outside world. Sometimes health visitors from outside who visit the baby in the unit share the knowledge of the baby's existence and can support the parents the better for it. The question was asked, however, why the funeral should not start from the parents' home, as is invariably the case in the Philippines and common in America. In the USA many people have family burial plots, and the baby would be collected by the parents, placed in a coffin and driven, sometimes quite a long distance, to the plot. In this way the baby remains part of the family.
It was felt there were situations when it was entirely appropriate for the dead child to go home, provided that the parents and siblings were supported; and this has been done from St George's.
Parental involvement in decision-making: Finally, attention turned to the degree of responsibility that parents should have in determining whether lifesupport machines are turned off. Dr McIntosh thought it was unfair to ask parents to make the decision on their own, and referred to a recent television programme in which the parents of a baby who had suffered a large intraventricular haemor-rhage had the whole burden of responsibility placed on their shoulders. He felt that after 15 years clinical experience he had some judgment as to how a baby would turn out, and felt that parents needed his opinion to help them make their decisions. It was felt that much guilt may accompany the parents' decision not to have something done, and that this can interfere with mourning when the child dies if there is no opportunity for sympathetic discussion. One paediatrician wondered if the grieving of a parent who had been intimately involved in a decision to withdraw care from a child because death was inevitable, might be different from that of a parent who could feel that everything possible was done for the child 'till the last possible moment'. Dr Lewis felt that it was not possible to answer such a question.
In drawing the meeting to a close, Ms Bender said that she felt the Forum had been rather ambitious to think that it could deal in one evening with the difficulties that both staff and parents encounter, and the content and orientation of the discussion appeared to have borne that out. The meeting opened with a review of the development of recombinant DNA technology as it pertains to medicine, given by Professor Williamson. In order to make a contribution, the molecular biologist needs a reliable diagnosis, a quantitive measure of the severity of the disorder, and a candidate gene. Given these requirements, he then needs a gene probe, a suitable preparation of the patient's genome, and a technique that will permit hybridization of the probe to its corresponding genomic DNA as dictated by base pairing. A useful review of these aspects was given by Dr Barralle. Probes are now available for a number of genes that code for proteins involved in lipid metabolism, as for example insulin', apolipoproteins AI2 and All3 and the LDL receptor4. Members were given an outline of the steps involved in their preparation, from the production of a cDNA library, screening of the library for cDNA fragments corresponding to the gene of interest and its flanking regions, and the manufacture from these fragments of an isotopically-labelled probe.
Sally
The cDNA library The starting point in the production of a probe is generally the isolation of total mRNA from a tissue which synthesizes the protein of interest in optimal amounts. The enzyme reverse transcriptase is used to add deoxynucleotides to the strands of mRNA in 5'-3' sequence as directed by complementary base-pairing, to produce what is called complementary DNA (cDNA). Degradation of mRNA with alkali then leaves single-stranded cDNA which is converted to duplex cDNA by the enzyme DNA polymerase I of E. coli. The duplex cDNA is primed by a hairpin loop at one end which is subsequently trimmed off with the enzyme Si nuclease.
Duplex cDNA can be fragmented and cloned in a vector, usually a plasmid or bacteriophage. Fragmentation and recombination of DNA each employ an important class of enzyme which is central to the technology, the restriction-endonucleases and the DNA ligases respectively. The restriction endonucleases are found in certain bacteria and are so-called because of their ability to cleave foreign DNA at certain sequence-specific sites, thereby restricting the growth of infecting phage. They are named according to origin and chronological sequence of isolation, for example Eco RI from E. coli RY13. A common cloning vector is the plasmid 0141-0768/86 010053-03/$02.00/0 0 1986 The Royal Society of Medicine pBR322 which possesses genes that confer ampicillin and tetracycline resistance upon the host bacteria. Importantly, a restriction enzyme site lies within the gene for tetracycline resistance. Treatment of the duplex cDNA and pBR322 with the appropriate restriction enzyme splits the cDNA into numerous fragments of differing length and opens the circular plasmid DNA by cleavage within the tetracycline resistance gene. Complementary ends are generated on the fragments and at the point of cleavage of the vector. Upon admixture ofthe fragments and opened plasmids in appropriate proportion, many of the cDNA fragments are inserted within the tetracycline resistance gene and can be annealed in this position with DNA ligase. Such insertions destroy the function of the gene. There now exists a heterogeneous collection of hybrid plasmids able to confer ampicillin resistance but not tetracycline resistance to a host bacterium, and to provide a source of reproduction of the inserted cDNA. (With further sophistication of the vector, it is possible to insert strong promoters adjacent to the inserted material in order to maximize gene expression.) The plasmids in which the break was ligated without insertion of cDNA retain the ability to confer tetracycline resistance. Bacteria (mutants of E. coli K12 are commonly used) can be persuaded to take up plasmids by pretreatment with Ca Cl2. Those that take up plasmids will grow on an ampicillin plate. Of these, the subgroup with chimaeric plasmids will fail to grow in a tetracycline medium, and can be harvested after destruction of growing cells with cycloserine. These surviving bacterial colonies represent the cDNA library.
Screening the cDNA library Somewhere within the library may lie colonies which contain cDNA sequences of interest. They can be detected by DNA-DNA or DNA-RNA hybridization with a suitable isotopically-labelled oligonucleotide probe. This probe is generally a synthetically constructed sequence complementary with a selected oligopeptide sequence within the protein for genetic study. Basically, the library of colonies is systematically plated on nitrocellulose filters. These master plates are replicated for probing and then held at low temperature. Colonies on the replicate plates are lysed and their DNA denatured without disturbance of their position. The prepared replicates are then exposed to the probe and any hybridization detected by radioautography. Identified colonies are taken from the master plates as a source of relevant genetic material free of the many thousands of other fragments of cDNA in the original library.
Making a probe
Chimaeric plasmid cDNA can be isolated, fragmented with one or more restriction enzymes, and radiolabelled by nick translation with E. coli DNA polymerase 1. Nicks are introduced along the cDNA with the enzyme DNA-ase 1. When isotopically labelled deoxynucleotides -are provided as substrate, DNA polymerase will add residues sequentially at the 3' end as directed by base pairing, with concomitant removal of the 5'-phosphoryl residue. Under appropriate conditions, between 25 and 50% of nucleotides can be replaced in this way. The end-product is a labelled genetic probe.
Preparation ofgenomic DNA for hybridization to probe The patient's DNA can be isolated from a number of sources (e.g. leukocytes, tissue cultures, chorionic villi) and digested with one or more restriction enzymes. The digest is electrophoresed either on agarose or polyacrylamide gel to produce a 'smear' of about 106 genomic fragments. This smear then has to be lifted from the gel and fixed in a manner that will allow hybridization of the probe to any fragments which it recognizes. The technique commonly employed is that described by Southern5. The gel is first exposed to alkali to convert the duplex DNA into single-stranded fragments. These fragments are raised from the gel onto an overlying nitrocellulose filter by 'sandwiching' the preparation between filter paper soaked in saline/citrate under the gel and dry filter paper over the, nitrocellulose. The saline/ citrate moves from wet to dry filter, carrying with it the smear which becomes trapped in the cellulose nitrate strip. After baking in a vacuum oven, the strip is exposed to the probe and hybridization detected by autoradiography. The size of any fragments which hybridize with the probe is measured in kilobases (kb) as judged from a commercially prepared digest of phage which is run to serve as a marker.
Restriction fragment length polymorphism While gene alterations are rarely encountered, genomic DNA that is not directly involved in coding appears to be more variable. On occasion these variations in the intervening and flanking region of genes (nucleotide sequence polymorphisms) alter the arrangement of sequences of one or more restriction enzyme sites along the ch;-omosome. This is the origin of restriction fragment length polymorphism (RFLP). These polymorphisms can be used as genetic markers, close to the coding sequence of interest, with which to trace the inheritance of suspected genetic disorders in families and populations. The application of this technique to the hyperlipidaemias and diabetes mellitus was described by Dr Humphries and Dr Galton, who used several illustrative examples.
RFLP for the apolipoprotein AI (apo-AI) gene
Two examples were mentioned. Rees et al.6 found that their apo-AI probe typically hybridized with a 5.7 kb and a 4.2 kb fragment in Southern blots of a Sst 1 digest of normal subjects. In 10 of 35 adults with hypertrigylceridaemia, the probe hybridized with an additional 3.2kb fragment which was observed in only 3 of 73 normolipidaemic subjects. This suggests a defect in the apo-AI gene that cosegregates with the RFLP in some hypertriglyceridaemic patients.
Norum et al.7 described two adult sisters in whom an absence of plasma apo-AI and apoCIII was associated with premature atherosclerosis. When their DNA was digested with Eco RI, the apo-AI probe hybridized with a 6.5 kb fragment, whereas in healthy subjects it hybridized with a 13 kb fragment. Parents and siblings possessed both bands (heterozygotes) and subnormal concentrations of plasma high-density lipoprotein (HDL) showing the disorder to be transmitted as an autosomal recessive8.
RFLP for the apo-AII gene Dr James Scott mentioned his recent study of healthy men in which evidence was found for linkage of the apo-AII gene with a RFLP that influenced HDL com-position9. When DNA from 87 men was digested with Msp I, the apo-AII probe hybridized with a 3 kb fragment in 62, a 3.7 kb fragment in 8, and with both fragments in 17. Homozygotes for the 3.7 kb fragment had an increased plasma apo-AII concentration without alteration of apo-AI or HDL cholesterol . Dr Galton emphasized that the association was not strong enough to be diagnostic but suggested that it might serve to define a subgroup of patients for further study. Dr Galton described work from his own laboratory on RFLP for the insulin gene in hypertriglyceridaemia' 7. Homozygosity for the 4.8 kb allele in Bgl I was found more frequently in diabetes with than without hypertriglyceridaemia. Mention was also made of a report from Owerbach et al.'8 of an increased prevalence of the 4.8 kb fragment in adults with a history of atherosclerotic disease. However, the finding requires independent confirmation.
Polygenic inheritance
Dr Humphreys discussed the possibility of analysis of polygenic disorders of lipid metabolism by simultaneous application of probes for several genes. His laboratory is using this approach to trace the inheritance of a number of genes within families and to correlate the pattern of inheritance with plasma lipoprotein concentrations. The underlying concept is that some alleles which in themselves do not give rise to clinical disease may nevertheless be suboptimal for lipid metabolism and contribute to hyperlipidaemia when inherited in combination with certain alleles for other genes. Familial type III hyperlipidaemia was used as an example. In this rare disorder which leads to premature atherosclerosis, the majority of patients are homozygous for the E2 phenotype of apolipoprotein E, and at least 95% possess one E2 allele'9. However, the population frequencies of the E2 phenotype and type III hyperlipidaemia are 1% and 0.01% respectively. Thus other factors must be involved other than inheritance of the E2 allele. Other family members often have type IIa or IIb hyperlipidaemia, which would be consistent with the presence of other inherited characteristics in these patients. Vella et al.20 have shown, however, that there is no coinheritance of the insulin allele linked to non-insulin-dependent diabetes with the apo-AI allele associated with hypertriglyceridaemia.
The meeting closed on an optimistic note. The pathogenesis of atherosclerosis is likely to have a strong but complex genetic background, with inheritance playing a major role not only in lipid and glucose metabolism, but also in blood pressure regulation and immune responses, all of which can affect endothelial integrity. A promising start has nevertheless been made, and increasingly sophisticated techniques are likely to appear within the near future to permit better opportunities for work in this largely unexplored field.
